Coronavirus Cure

In 1952, a college lecturer in Gujarat set out to prove that an indigenous company could provide world-class and affordable medicines.

As of now, there are more than 155 vaccine candidates, and 23 of them have reached the human trial stage.

Biocon Limited, has received the Drug Controller General of India’s (DCGI) approval to market ‘Itolizumab,’ a drug previously used to treat chronic plaque psoriasis, for restricted emergency use on COVID-19 patients.

“As of yet, the situation hasn't become very difficult to handle. But the next 10-15 days will be very critical because by this time we will come to know whether the virus is being contained or whether it is going out of our hands."